| Resistant to most effective first-line and some second-line TB drugs. |
Patient cannot tolerate prescribed medications or infection does not respond to treatment. |
| More dangerous and difficult to treat than MDR TB. |
Requires exploration of alternative treatment regimens. |
| Limited treatment options, higher mortality, and increased transmission risk. |
Adjustments in drug combinations or dosages may be needed. |
| Spreads rapidly, posing a serious public health threat. |
Crucial to prevent development of extensively drug-resistant strains. |
| Requires preventive measures and early diagnosis. |
Identifying reasons for treatment intolerance and providing support. |